Composition and properties

UrgoTul® Absorb Border is an absorbent foam dressing with a silicone adhesive border and shower-proof backing. It is based on the exclusive and patented TLC (Technology Lipido-Colloid).

TLC at the heart, silicone at the border

Providing all the benefits of TLC (Technology – Lipido Colloid)

  • Moist Wound Healing Environment (1,2)
  • Increased stimulation of fibroblast proliferation (3,4)
  • Promotes wound healing
  • Optimises reconstruction of dermis and epidermis
  • Improvement of surrounding skin (5)
  • Less risk of maceration
  • Clinically proven in over 36,000 patients (6)
  • Pain-free dressing change (1,7,8)
  • No trauma or disturbance to the wound bed

 

Indications

  • UrgoTul® Absorb Border is indicated for the treatment of low-moderately exuding wounds
  • Acute wounds: Minor burns, traumatic wounds, dermabrasions, post-operative wounds
  • Chronic wounds: Arterial leg ulcers, mixed aetiology leg ulcers, and pressure ulcers

 


Sizes

 

Size Pack Size Product
Code
NHS Code

(Blue Diamond*)
PIP Code
8 x 8cm 10 550866 ELA660 386-7132
10 x 10cm 10 551014 ELA661 386-7140
13 x 13cm 10 550867 ELA662 386-7157
15 x 20cm 10 550868 ELA663 386-7165
20 x 20cm (Sacral) 5 550869 ELA664 386-7173

*Delivery time: 5 days from receipt to order

Also available in a sacral version

Structure of the absorbent and adhesive foam dressing


 


Absorbent foam dressing with a silicone adhesive border

For the management of acute and chronic exuding wounds

  • TLC healing matrix to optimise healing when in contact with the wound
  • Absorbent layer
  • Pain-free and atraumatic removal for the patient (1,7,8)
  • 17% Less expensive than the average foam adhesive border dressing (9)

 

Patient Experiences using UrgoTul® Absorb Border

 

 

 

References

 

  • (1) Benbow M., Iossen G. A clinical evaluation of Urgotul to treat acute and chronic wounds. Br J Nurs 2004: 13(2): 105-109.
  • (2) Winter G.D. Formation of the scab and rate of epithelialisation of superficial wounds in the skin of the young domestic pig. Nature 1962; 193: 293-294.
  • (3) Bernard F.X. et al. Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipido-colloid dressing J Wound Care 2005; 14 (5): 215-220.
  • (4) Urgotul®. Data on file, 2010. Urgo.
  • (5) Fays S. et al. Leg ulcers and the Urgocell Non-Adhesive wound dressing. Br J Nurs 2005: 14 (11):S15-20.
  • (6) White R., Cowan T., Glover D. Supporting evidence based practice: a clinical review of TLC technology. Published in JWC, March 2011.
  • (7) Smith J. et al. Evaluation of Urgotul plus K-four compression for venous leg ulcers, Br J Nurs 2004: 13 (6): S20-28.
  • (8) Meaume S., Téot L. et al. The importance of pain reduction through dressing selection in routine wound management. Journal of Wound Care, 2004; 13 (10).
  • (9) IMS Wounds Data. Units split Period January 2013 - December 2013. (Mepilex Border, Allevyn Gentle Border, Allevyn Life, Allevyn Adhesive, Biatain Silicone, Aquacel Adhesive Border, Tegaderm Adhesive Border).